<\/p>\n
Elocon Cream<\/strong> is a topical 0.1% mometasone furoate cream from Schering-Plough \/ MSD — a siln\u00fd topick\u00fd kortikosteroid (t\u0159\u00edda III ve Velk\u00e9 Brit\u00e1nii \/ t\u0159\u00edda III-II v USA)<\/strong> used for short-term treatment of steroid-responsive inflammatory skin conditions including eczema (atopic dermatitis), psoriasis vulgaris, contact dermatitis, lichen planus, discoid lupus, seborrhoeic dermatitis of the scalp\/body<\/strong>, and other dermatoses. Apply a thin film once daily<\/strong> to affected areas; mometasone’s once-daily dosing is a key advantage over most other potent steroids. Maximum course 2–4 weeks on the body<\/strong> a 5–7 days only on the face<\/strong>. Do NOT use on rosacea, acne, perioral dermatitis, broken skin, or untreated skin infection — mometasone worsens<\/strong> these conditions.<\/p>\n<\/div>\n \ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n Elocon Cream is the original Schering-Plough (now Merck \/ MSD) brand of 0.1% mometasone furoate \u2014 the molecule that defined the potent once-daily topical steroid class.<\/p>\n Elocon Cream is a 0.1% mometasone furoate<\/strong> topical cream, manufactured by Schering-Plough \/ MSD and supplied in a 15 g tube. Mometasone furoate is a synthetic glucocorticoid (corticosteroid) classified as a potent topical steroid<\/strong> (UK Class III). It was specifically engineered for topical use — its metabolism by skin esterases to inactive metabolites means systemic absorption after topical application is low<\/strong>, giving it one of the best therapeutic windows of any potent topical corticosteroid.<\/p>\n Mometasone binds intracellular glucocorticoid receptors in keratinocytes, dermal fibroblasts, and infiltrating inflammatory cells. The activated receptor suppresses transcription of pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-α), inhibits phospholipase A2<\/sub>, and promotes apoptosis of T-lymphocytes infiltrating the inflamed skin. The result is rapid suppression of the inflammatory cascade driving eczema and psoriasis flares.<\/p>\n Onset: 24–48 hours for itch and redness; full response at 1–2 weeks.<\/p>\n D\u00e1vkov\u00e1n\u00ed topick\u00fdch steroid\u016f vyu\u017e\u00edv\u00e1 jednotku kone\u010dku prstu (FTU)<\/strong>: the amount squeezed from a 5 mm-nozzle tube along an adult index finger from tip to first crease. 1 FTU \u2248 0,5 g<\/strong> treats an area about the size of two adult palms.<\/p>\n FTU per adult body region:<\/strong><\/p>\n Postup aplikace:<\/strong><\/p>\n Local (more common with prolonged use, occlusion, or thin-skin sites):<\/strong><\/p>\n Systemic (rare at recommended dose; real risk with high-dose, large-area, prolonged, or occlusive use):<\/strong> HPA-axis suppression, iatrogenic Cushing’s syndrome, hyperglycaemia, glaucoma\/cataract from periocular use, growth suppression in children.<\/p>\n Stopping a potent topical steroid abruptly after more than 2–3 weeks of daily use commonly triggers a rebound flare<\/strong> — original eczema or psoriasis returns, often worse than baseline, sometimes with burning or topical steroid withdrawal syndrome (TSWS).<\/p>\n Step-down strategies used in dermatology:<\/p>\n T\u011bhotenstv\u00ed:<\/strong> avoid extensive or prolonged use. Brief use over small area for essential indication is generally considered acceptable. High cumulative topical-steroid exposure in pregnancy has been associated with low birth weight.<\/p>\n Store below 25°C. Replace cap tightly after each use. Keep out of reach of children. Use within 3–6 months of opening or before the expiry date, whichever is sooner.<\/p>\n Ne.<\/strong> Mometasone (like all potent topical steroids) can trigger or worsen steroidn\u00ed rosaceu<\/em> — persistent redness, telangiectasia, papules and pustules appearing after days to weeks of facial steroid use. If you have rosacea, use topical ivermectin 1% (Ivrea Cream)<\/a>, azelaic acid (Aziderm)<\/a>, nebo brimonidine gel (Erythego)<\/a> — the evidence-based rosacea topicals.<\/p>\n Relief of itch and redness within 24–48 hours. Full response in 1–2 weeks for eczema; psoriasis plaques may take 2–4 weeks for meaningful thinning. If no improvement at 2 weeks, stop and review the diagnosis — fungal infection mistaken for eczema is the most common reason.<\/p>\n Facial skin is thinner and more permeable than body skin, so systemic absorption is 6–15× higher from the face. The risk of perioral dermatitis, steroid-induced rosacea, telangiectasia, and irreversible atrophy rises steeply beyond 1 week of facial use. For facial inflammation, a mild steroid (hydrocortisone 1%) or a topical calcineurin inhibitor (tacrolimus, pimecrolimus) is the appropriate choice.<\/p>\n No — occlusion multiplies systemic absorption up to ten-fold and dramatically raises the risk of atrophy and HPA-axis suppression. Occluded steroid therapy is a specialised dermatology technique used only under direct supervision.<\/p>\n Children have more permeable skin and higher risk of growth suppression and HPA-axis effects from potent topical steroids. Generally not for under 2 years. In ages 2–12, used only under paediatric dermatology supervision — preferred starting agents are mild steroids (hydrocortisone 1%) or topical calcineurin inhibitors (tacrolimus 0.03%).<\/p>\n Klasick\u00fd steroidn\u00ed rebound flare<\/strong> from abrupt discontinuation. Restart, then plan a tapered step-down — moderate-potency steroid for 1–2 weeks, then mild, then emollient ± topical calcineurin inhibitor for long-term maintenance.<\/p>\n Avoid extensive or prolonged use. Brief use over a small area for an essential flare is generally considered acceptable. High cumulative topical-steroid exposure during pregnancy has been associated with low birth weight in some studies. Discuss with your obstetrician.<\/p>\n You can buy Elocon Cream (mometasone 0.1% cream, 15 g tube) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n <\/p>\n Dal\u0161\u00ed produkty v Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n Elocon Cream is the Merck\/MSD (originally Schering-Plough) brand of 0.1% mometasone furoate \u2014 a potent once-daily topical corticosteroid (UK Class III) for eczema, psoriasis vulgaris, contact dermatitis, lichen planus, discoid lupus, seborrhoeic dermatitis. Apply thin film once daily \u2014 mometasone’s key advantage over twice-daily steroids. Maximum 2\u20134 weeks on body sites. Not for rosacea, acne, or perioral dermatitis.<\/p>","protected":false},"featured_media":59231,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3563],"product_tag":[4652,4653],"class_list":{"0":"post-59230","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-rosacea-treatment","9":"product_tag-elocon-cream","10":"product_tag-momentasone","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/59230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=59230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/59231"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=59230"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=59230"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=59230"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=59230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
What Is Elocon Cream?<\/h2>\n
How Elocon Cream Works<\/h2>\n
Schv\u00e1len\u00e9 indikace<\/h2>\n
\n
Elocon Cream Dosage — the Fingertip Unit Rule<\/h2>\n
\n
\n
Where NOT to Apply Elocon Cream<\/h2>\n
\n
Vedlej\u0161\u00ed \u00fa\u010dinky a bezpe\u010dnost<\/h2>\n
\n
How to Stop Elocon Cream — Avoiding Rebound<\/h2>\n
\n
Kontraindikace & T\u011bhotenstv\u00ed<\/h2>\n
\n
Skladov\u00e1n\u00ed<\/h2>\n
\u010casto kladen\u00e9 dotazy<\/h2>\n
Can I use Elocon Cream for rosacea?<\/h3>\n
How long does Elocon Cream take to work?<\/h3>\n
Why is the face limit only 5–7 days?<\/h3>\n
Can I cover Elocon Cream with a bandage?<\/h3>\n
Can children use Elocon Cream?<\/h3>\n
My eczema came back worse when I stopped — why?<\/h3>\n
Is Elocon Cream safe in pregnancy?<\/h3>\n
Where can I buy Elocon Cream online?<\/h3>\n
Souvisej\u00edc\u00ed l\u00e9\u010dba na MedsBase<\/h2>\n
\n
Souvisej\u00edc\u00ed alternativy<\/h3>\n
\n